Markets

Becton, Dickinson (BDX) Beats on Q4 Earnings and Revenues

Becton, Dickinson and Company BDX, also known as BD, reported fourth-quarter fiscal 2019 earnings per share (EPS) of $3.31, which beat the Zacks Consensus Estimate by a penny. The bottom line also improved 13% on a year-over-year basis and rose 12.3% at constant currency (cc).

FY19 at a Glance BD Medical BD Life Sciences BD Interventional

Becton, Dickinson and Company Price, Consensus and EPS Surprise

 

Becton, Dickinson and Company Price, Consensus and EPS Surprise

Becton, Dickinson and Company price-consensus-eps-surprise-chart | Becton, Dickinson and Company Quote

Segment Details BD Medical BD Life Sciences BD Interventional Geographic Results US International Margin Analysis Guidance Wrapping Up Earnings of Other MedTech Majors at a Glance EW TMO RMD the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here More Stock News: This Is Bigger than the iPhone!

Click here for the 6 trades >>


Click to get this free report

Thermo Fisher Scientific Inc. (TMO): Free Stock Analysis Report

Edwards Lifesciences Corporation (EW): Free Stock Analysis Report

ResMed Inc. (RMD): Free Stock Analysis Report

Becton, Dickinson and Company (BDX): Free Stock Analysis Report

To read this article on Zacks.com click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics

Stocks